Tong Xiaoxia, Zhu Ting, Ma Li, Yang Xiaohu, Li Chenghui, Liu Yibing, Qin Xuan, Ding Yanguang, Xia Hongwei, Liu Yonglei
Experimental Research Center, Qingpu Hospital Affiliated to Fudan University, 1158 Park Road(E), Shanghai, Shanghai, 201700, China.
Department of Pathology, Qingpu Hospital Affiliated to Fudan University, Shanghai, China.
BMC Cancer. 2025 Jun 5;25(1):1001. doi: 10.1186/s12885-025-14341-3.
Cathepsin C (CTSC) is a cysteine protease in lysosomes that controls immunological responses. Upregulation CTSC expression was reportedly related with tumor progression and metastasis. The roles and mechanisms of CTSC in non-small cell lung cancer (NSCLC) are still unclear. Through systematic analysis, we found that the level of CTSC was higher in NSCLC and it was correlated with the overall survival (OS) of NSCLC patients. Furthermore, single-cell sequencing (scRNA-seq) analysis suggested that the vast majority of CTSC was expressed in epithelial cell, NK cell, M1 and M2 macrophages, and neutrophil. Gene set enrichment analysis (GSEA) demonstrated the involvement of CTSC in the immune responses and ssGSEA, CIBERSORT-abs, QUANTISEQ, XCELL algorithms results showed CTSC was positively associated with the M2 macrophages infiltration. Besides, CTSC was significantly co-expressed with M2 macrophage maker genes (CD68, CD163), and immune checkpoints. Then, CTSC, CD68, CD163 expression levels were detected by immunohistochemistry in our clinical NSCLC cohort. Subsequently, the regulatory roles of CTSC in the progression and metastasis of NSCLC were investigated both in vitro and in vivo. Our results indicated that knocking down CTSC in NSCLC cell lines restrained cell proliferation and migration. CTSC overexpression in NSCLC cells showed the opposite effects. Targeting CTSC may provide a promising treatment strategy for NSCLC patients.
组织蛋白酶C(CTSC)是溶酶体中的一种半胱氨酸蛋白酶,可控制免疫反应。据报道,CTSC表达上调与肿瘤进展和转移有关。CTSC在非小细胞肺癌(NSCLC)中的作用和机制仍不清楚。通过系统分析,我们发现NSCLC中CTSC水平较高,且与NSCLC患者的总生存期(OS)相关。此外,单细胞测序(scRNA-seq)分析表明,绝大多数CTSC在上皮细胞、自然杀伤细胞、M1和M2巨噬细胞以及中性粒细胞中表达。基因集富集分析(GSEA)证明CTSC参与免疫反应,单样本基因集富集分析(ssGSEA)、CIBERSORT-abs、QUANTISEQ、XCELL算法结果显示CTSC与M2巨噬细胞浸润呈正相关。此外,CTSC与M2巨噬细胞标志物基因(CD68、CD163)以及免疫检查点显著共表达。然后,我们在临床NSCLC队列中通过免疫组织化学检测CTSC、CD68、CD163的表达水平。随后,在体外和体内研究了CTSC在NSCLC进展和转移中的调控作用。我们的结果表明,敲低NSCLC细胞系中的CTSC可抑制细胞增殖和迁移。NSCLC细胞中CTSC过表达则显示出相反的效果。靶向CTSC可能为NSCLC患者提供一种有前景的治疗策略。